Dimensional Fund Advisors LP Passage Bio, Inc. Transaction History

Dimensional Fund Advisors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$1.06 - $1.48 $1,371 - $1,915	-1,294 Reduced 6.67%	18,114 $24,000
Q3 2022 Nov 10, 2022	BUY	$1.22 - $2.48 $1,578 - $3,209	1,294 Added 7.14%	19,408 $24,000
Q2 2022 Aug 12, 2022	SELL	$1.63 - $3.46 $1,048 - $2,224	-643 Reduced 3.43%	18,114 $43,000
Q1 2022 May 13, 2022	SELL	$2.66 - $6.49 $11,698 - $28,543	-4,398 Reduced 18.99%	18,757 $58,000
Q4 2021 Feb 09, 2022	BUY	$6.24 - $10.2 $53,333 - $87,179	8,547 Added 58.51%	23,155 $147,000
Q3 2021 Nov 12, 2021	BUY	$9.73 - $15.52 $142,135 - $226,716	14,608 New	14,608 $145,000

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $35.9M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.